Furthermore, more patients maintained a TCS ≤1 at week 8 (1 month without treatment) in the Cal/BD foam arm, although it did not reach statistical significance ( P = 0.568).
← all excerpts
Non-invasive clinical and microscopic evaluation of the response to treatment with clobetasol cream vs. calcipotriol/betamethasone dipropionate foam in mild to moderate plaque psoriasis: an investigator-initiated, phase IV, unicentric, open, randomized clinical trial.
1
0.5680
0.5680